In vivo photoacoustic tomography of EGFR overexpressed in hepatocellular carcinoma mouse xenograft

Photoacoustics

Quan Zhou¹  Thomas D. Wang¹  Xiyu Duan¹  Rork Kuick²  Zhao Li³  Gaoming Li⁴  Juan Zhou⁴  Bishnu P. Joshi⁴  Scott R. Owens⁵ 

[1] Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, United States;Department of Biostatistics, University of Michigan, Ann Arbor, MI 48109, United States;Department of Hepatobiliary Surgery, Peking University People’s Hospital, Beijing, China;Department of Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, MI 48109, United States;Department of Pathology, University of Michigan, Ann Arbor, MI 48109, United States;

关键词: Hepatocellular carcinoma;    Epidermal growth factor receptor (EGFR);    Photoacoustic;    Imaging;    Peptide;   

DOI  :  10.1016/j.pacs.2016.04.001

来源: DOAJ

【 摘 要 】

EGFR is a promising cell surface target for in vivo imaging that is highly overexpressed in hepatocellular carcinoma (HCC), a common cancer worldwide. Peptides penetrate easily into tumors for deep imaging, and clear rapidly from the circulation to minimize background. We aim to demonstrate use of an EGFR specific peptide to detect HCC xenograft tumors in mice with photoacoustic imaging. Nude mice implanted with human HCC cells that overexpress EGFR were injected intravenously with Cy5.5-labeled EGFR and scrambled control peptides respectively. Photoacoustic images collected from 0 to 24 h. Photoacoustic signal peaked in tumors at 3 h post-injection. Images from 0 to 1.8 cm beneath the skin revealed increased target-to-background (T/B) ratio from tumors. The T/B ratio was significantly greater for the EGFR versus control peptide. Clearance of signal was observed by ∼24 h. EGFR overexpression was validated with immunofluorescence and immunohistochemistry. A peptide specific for EGFR delivered systemically can detect HCC xenograft tumors in vivo with photoacoustic imaging.

【 授权许可】

Unknown